Antibodies 2022, 11(3), 56; https://doi.org/10.3390/antib11030056 - 26 Aug 2022
Best Paper Award
The Antibodies Best Paper Award is granted annually to highlight publications of high quality, scientific significance, and extensive influence. The evaluation committee members choose one article of exceptional quality that has been published in the journal in the previous year and announce it online by the end of July.
The Prize:
– One research article/review is selected.
– Each winner receives CHF 500, a certificate, and a free voucher for article processing fees valid for one year.
Antibodies Best Paper Award
Winner announcement: 31 December 2025
Eligibility and Requirements
– All papers published in Antibodies are eligible (both regular and Special Issue submissions).
Selection Criteria
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity in the study design or uniqueness in the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
Past Winners
Year:
Winner
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Award Committee
Prof. Arne Skerra
Chairman
Dr. Pablo Engel
Department of Biomedical Sciences
Prof. Dr. Buyong Ma
Prof. Mattias Collin
Lund University
Winner
Mark L. Chiu
Drug Product Development Science, Janssen Research & Development, LLC, Malvern, PA 19355, USA
